Targeted dosing to treat pediatric inflammatory bowel disease is challenging because dosing guidelines are based on data gathered from adult subjects of clinical trials. Patients’ families and health care organizations also incur high costs and must try to balance potential benefits against risks of ongoing monitoring.
AMA J Ethics. 2018;20(9):E841-848. doi:
10.1001/amajethics.2018.841.
Dr Chad M. Teven joins Ethics Talk to unravel some current and a few hoped-for surgical applications of AI and to model for us how we should be critically engaging with AI surgical research and scholarship.
Nubia Chong, MD, Maria Mirabela Bodic, MD, Peter Steen, MD, Ludwing Salamanca, MD, PhD, and Stephanie LeMelle, MD, MS
Paternalistic language in patients’ health records is of specific ethical concern because it emphasizes clinicians’ power and patients’ vulnerabilities and can be demeaning and traumatizing.
AMA J Ethics. 2024;26(3):E225-231. doi:
10.1001/amajethics.2024.225
Inpatient psychiatric units are designed around the twin aims of treatment and containment, but emotional norms and tone also contribute to care environments.
AMA J Ethics. 2024;26(3):E232-236. doi:
10.1001/amajethics.2024.232.
Dr Peter Steen joins Ethics Talk to discuss his article, coauthored with Drs Nubia Chong, Maria Mirabela Bodic, Ludwing Salamanca, and Stephanie LeMelle: “What Should Students and Trainees Learn About Patient-Centered Documentation?”
The objective is to compare the costs of providing the same level of quality. When resource-use and quality measures are juxtaposed, the resources used to provide the same level of quality can be compared.
When talking to physicians about practice variation, “Why does hospital A have higher cesarean rates than Hospital B?” is likely to be more effective than “Why does Doctor A have higher cesarean rates than Doctor B?”
Thomas W. LeBlanc, MD, MA and Amy P. Abernethy, MD, PhD
One strategy to promote adherence is the use of “care pathways,” effectively roadmaps that seek to standardize cancer treatment on the basis of some agreed-upon set of guidelines within a particular center or group of patients.
Nonmaleficence must not be sacrificed in the name of the patient’s autonomy, but there is no need to undertake needlessly invasive treatments for a small boost in protection against cancer recurrence if the patient does not wish to do so.
It is an understandable human reaction to feel defensive in the face of evidence that challenges one's practices, but it is imperative that we rise above this with a modicum of humility and ask the tough questions: what causes problems and how can we avoid them in the future?